A discussion on Chronic Care Policy Alliance’s priorities and tips on how to reach out to elected officials.
Patient messaging for prescription access and affordability Issues: Communicating with legislators
read more
Role of state regulators in addressing discriminatory benefit design
Carl Schmid presents at National Association of Insurance Commissioners, along with other consumer representatives, on discrimination in insurance benefit design with a focus on prescription drugs and adverse tiering.
Role of PBMs in patient access & affordability of prescription drugs & potential solutions
HIV+Hep’s Carl Schmid, a consumer representative to the National Association of Insurance Commissioners (NAIC), presents to the NAIC PBM subgroup, along with ACSCAN’s Anna Howard, on how PBM’s impact patient access and affordability of prescription drugs.
Patient Community Perspective
Details the harmful impacts copay accumulators have on drug adherence and patients costs, federal and state actions taken to date to ensure copay assistance counts, and advocacy opportunities at the federal and state levels patient groups can engage in relative to copay accumulators.
Searching for savings: An innovative approach to pay for prescriptions
Examines how insurance benefit design, including high deductibles and co-insurance, impact prescription drug access, along with the importance of copay assistance and how states are ensuring that it count towards beneficiary cost-sharing obligations.